CardioSignal Inc

We develop digital cardiac biomarkers for earlier detection of heart diseases. With the ambition to take heart disease detection accessible to billion smartphone users, CardioSignal addresses the challenge of delayed diagnosis and growing disparity in heart disease care. Our novel motion sensor technology non-invasively measures cardiac motion and function. Originally an academic spinoff, the company’s patented technology is built on a decade of research and algorithm development.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved